Octave Specialty Group: Third Quarter 2026 Earnings Call - OCTAVE SPECIALTY GROUP INC

Financial Performance:

• Reported a net loss to shareholders of $13.8 million ($0.31/share) for Q3 2026, an improvement of $17.9 million ($0.34/share) versus the prior year.
• Consolidated Adjusted EBITDA to shareholders was positive $3.3 million, compared to a negative $2.9 million in the prior year quarter.
• Insurance Distribution segment revenue grew 35% YoY to $58 million (23% organic growth); Year-to-Date Adjusted EBITDA to shareholders nearly tripled to $43.4 million with margins expanding to 22.2%.
• Specialty P&C segment (Everspan) reported Adjusted EBITDA of $2.2 million vs. <$0.1 million prior year; Net premiums written and earned grew 44% and 52% respectively.
• Combined ratio improved significantly to 100.6% (vs. 112.9% prior year), driven by a 57.1% loss ratio (vs. 84.5% prior year).
• Net debt-to-EBITDA leverage ratio fell below 3.0x at quarter-end; corporate expenses reduced 20% to $10 million for the quarter.
• Total top-line growth for the Insurance Distribution segment is on track to exceed full-year guidance of 25%+ organic growth.

Guidance and Future Outlook:

• Confirmed ability to meet or exceed full-year 2026 adjusted net income per share guidance, marking a projected shift to positive adjusted net income for the first time since 2021.
• Targeting $80 million in consolidated Adjusted EBITDA to shareholders by 2028.
• 2027 capacity is largely secured and expected to be oversubscribed.
• Fourth quarter Organic growth will include the full impact of the ArmadaCare acquisition, which closed Oct 31, 2025, shifting from inorganic to organic calculation.
• Everspan full-year gross premiums written guidance may be slightly below $410 million due to business mix shifts and new program ramp timing; Adjusted EBITDA guidance of $6 million remains attainable.
• Expect double-digit organic growth in the fourth quarter of 2026.

Business Segments and Product Lines:

• Insurance Distribution: Driven by organic growth, a successful MGA portfolio (Class 2024/2025), and the ArmadaCare acquisition; launched seven product adjacencies year-to-date and three new programs in recent weeks.
• A&H Segment: Constitutes ~33% of the portfolio, benefiting from double-digit rate increases due to healthcare costs; serves as a hedge against P&C market cycles.
• Specialty P&C (Everspan): Repositioning portfolio toward casualty and non-CAT property; added three new programs to diversify risk; plan to simplify structure by selling subsidiary Providence Washington Insurance Company (TWIC) by early next year.
• Technology & AI: AI-driven intake rollout for US MGAs largely complete; utilizing AI to enhance underwriting velocity and productivity rather than disintermediate distribution.

Market and Competitive Landscape:

• P&C markets face abundant capacity and declining rates (global commercial rates down for 9 consecutive quarters); Property rates fell ~10% in Q3.
• Casualty SME and select specialty classes remain attractive with double-digit rate increases; London casualty markets remain competitive but rates holding better than property.
• A&H sector operating on a different cycle with firm rates and strong tailwinds.
• Octave remains selective with MGA partnerships, focusing on proven teams in specialist niches where pricing adequacy is high.
• E&S market has seen significant capital movement, increasing competition.

Risks and Challenges:

• Energy segment faces compounding rate reductions and elevated loss experience, viewed as unsustainable.
• Commercial auto book continues to face adverse development due to social inflation and regulatory impacts, though reserves are being managed and books are exiting.
• New program launches and business mix shifts in Everspan create uncertainty regarding Q4 premium ramp rates.
• AI disruption fears persist, though management argues AI enhances productivity in complex specialty lines.

Management Commentary and Tone:

• Tone is highly confident and optimistic regarding the strategic pivot to a diversified MGA platform.
• Management emphasizes strong execution, cost discipline (20% corporate cost reduction), and the strategic advantage of their AI-integrated technology stack.
• Expressed confidence that current market valuation does not fully reflect the company's fundamental value and future earnings power.
• Management remains focused on organic growth, integration, and strategic buy-ins of non-controlling interests rather than large-scale acquisitions.

Analyst Questions and Answers:

• Fee Seasonality: Servicing fees in Q3 were higher due to Armada acquisition; expected to level out in Q4.
• A&H Performance: Loss ratios in A&H are performing in line with or better than expectations due to strong rate increases.
• Everspan Growth: Q4 growth depends on the ramp of new programs added in Q3; earned/written ratio expected to remain consistent.
• MGA Pipeline: High enthusiasm for Octave's platform and equity offers, particularly in the US; expect to close 1-2 new teams this year/next year.
• ArmadaCare Impact: Minor impact in Q4 due to seasonality; significant positive impact expected in Q1 2027.
• Inorganic vs. Organic: No major acquisitions expected; focus is on organic growth, bolt-ons, and buy-ins.
• Commercial Auto Tail: Adverse development has normalized to ~1% annualized; management expects the 2021/2022 books to be fully closed out soon.

Other Key Points:

• The acquisition of ArmadaCare closed on October 31, 2025, with its revenue now factored into the organic growth metric starting in Q4 2026.
• A sale of the TWIC subsidiary will result in an estimated $4 million net gain and $11 million increase in tangible book value.
• Global integration of the target operating model is ongoing, with initial phases for international operations planned later in the year.